Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
The Mediating Role of Inflammation in the Association Between NHHR and Pelvic Inflammatory Disease: A Case-Control
Yanan Duan1, Yu Su2, Yiqing Peng3
1Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Background:
Pelvic inflammatory disease (PID) is a common infection among women of reproductive age, primarily caused by sexually transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae. Emerging evidence suggests that lipid metabolism may contribute to systemic inflammation and increased susceptibility to PID. This study aimed to explore the association between the non-high-density lipoprotein to high-density lipoprotein cholesterol ratio (NHHR) and PID, and to assess the mediating role of inflammatory markers.
Methods:
This retrospective case-control study included 2,247 women diagnosed with or without PID based on surgical and clinical records at a single tertiary hospital. Least absolute shrinkage and selection operator (LASSO) regression was used to identify candidate predictors, followed by multivariate logistic regression. A PID prediction model was developed and evaluated using training and validation datasets (7:3 split). Mediation analysis assessed the role of inflammatory markers, particularly white blood cell (WBC) count.
Results:
NHHR was significantly associated with PID (OR = 1.39, 95% CI = 1.16-1.66). Mediation analysis showed that WBC partially mediated the NHHR-PID relationship, accounting for 19.26% of the effect. The prediction model demonstrated strong discrimination, with AUCs of 0.825 (training) and 0.819 (validation).
Conclusion:
Higher NHHR levels are associated with an increased risk of PID, and systemic inflammation may partially mediate this relationship. NHHR may serve as a potential marker for PID risk stratification, though further external validation is warranted.
More Related Videos
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
08:02Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Gastritis II: Pathophysiology
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease II: Ulcerative Colitis
Acute Inflammation II: Local and Systemic Effects